skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 249  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The role of intestinal microbiota in cardiovascular disease
Material Type:
Article
Add to My Research

The role of intestinal microbiota in cardiovascular disease

Journal of cellular and molecular medicine, 2019-04, Vol.23 (4), p.2343-2350 [Peer Reviewed Journal]

2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14195 ;PMID: 30712327

Full text available

2
High‐mobility group box‐1 induces vascular remodelling processes via c‐Jun activation
Material Type:
Article
Add to My Research

High‐mobility group box‐1 induces vascular remodelling processes via c‐Jun activation

Journal of cellular and molecular medicine, 2015-05, Vol.19 (5), p.1151-1161 [Peer Reviewed Journal]

2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2015 Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2015. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12519 ;PMID: 25726846

Full text available

3
Transcriptomic analysis identifies Toll‐like and Nod‐like pathways and necroptosis in pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Transcriptomic analysis identifies Toll‐like and Nod‐like pathways and necroptosis in pulmonary arterial hypertension

Journal of cellular and molecular medicine, 2020-10, Vol.24 (19), p.11409-11421 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.15745 ;PMID: 32860486

Full text available

4
NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension
Material Type:
Article
Add to My Research

NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension

Journal of cellular and molecular medicine, 2021-01, Vol.25 (2), p.1221-1237 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16193 ;PMID: 33340241

Full text available

5
LncRNA PAXIP1‐AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis
Material Type:
Article
Add to My Research

LncRNA PAXIP1‐AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis

Journal of cellular and molecular medicine, 2021-08, Vol.25 (15), p.7321-7334 [Peer Reviewed Journal]

2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16761 ;PMID: 34245091

Full text available

6
Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China
Material Type:
Article
Add to My Research

Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China

Journal of cellular and molecular medicine, 2020-02, Vol.24 (4), p.2484-2496 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14937 ;PMID: 31945804

Full text available

7
Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway
Material Type:
Article
Add to My Research

Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway

Journal of cellular and molecular medicine, 2023-03, Vol.27 (5), p.622-633 [Peer Reviewed Journal]

2023 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.17681 ;PMID: 36762748

Full text available

8
Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
Material Type:
Article
Add to My Research

Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease

Journal of cellular and molecular medicine, 2018-12, Vol.22 (12), p.6249-6261 [Peer Reviewed Journal]

2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.13912 ;PMID: 30338626

Full text available

9
The protective effects of MSC‐EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway
Material Type:
Article
Add to My Research

The protective effects of MSC‐EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway

Journal of cellular and molecular medicine, 2020-12, Vol.24 (23), p.13938-13948 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16002 ;PMID: 33090702

Full text available

10
Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats
Material Type:
Article
Add to My Research

Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats

Journal of cellular and molecular medicine, 2015-08, Vol.19 (8), p.1965-1974 [Peer Reviewed Journal]

2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2015 John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12573 ;PMID: 25766467

Full text available

11
The preventive and therapeutic effects of AAV1‐KLF4‐shRNA in cigarette smoke‐induced pulmonary hypertension
Material Type:
Article
Add to My Research

The preventive and therapeutic effects of AAV1‐KLF4‐shRNA in cigarette smoke‐induced pulmonary hypertension

Journal of cellular and molecular medicine, 2021-01, Vol.25 (2), p.1238-1251 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16194 ;PMID: 33342082

Full text available

12
Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension

Journal of cellular and molecular medicine, 2022-05, Vol.26 (9), p.2633-2645 [Peer Reviewed Journal]

2022 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.17272 ;PMID: 35393789

Full text available

13
Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress
Material Type:
Article
Add to My Research

Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress

Journal of cellular and molecular medicine, 2021-11, Vol.25 (22), p.10389-10402 [Peer Reviewed Journal]

2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16968 ;PMID: 34609050

Full text available

14
Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertension
Material Type:
Article
Add to My Research

Identification of immune‐associated signatures and potential therapeutic targets for pulmonary arterial hypertension

Journal of cellular and molecular medicine, 2023-12, Vol.27 (23), p.3864-3877 [Peer Reviewed Journal]

2023 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2023 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.17962 ;PMID: 37753829

Full text available

15
Sodium butyrate attenuates angiotensin II‐induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6‐dependent mechanism
Material Type:
Article
Add to My Research

Sodium butyrate attenuates angiotensin II‐induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6‐dependent mechanism

Journal of cellular and molecular medicine, 2019-12, Vol.23 (12), p.8139-8150 [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14684 ;PMID: 31565858

Full text available

16
Construction of a ceRNA coregulatory network and screening of hub biomarkers for salt‐sensitive hypertension
Material Type:
Article
Add to My Research

Construction of a ceRNA coregulatory network and screening of hub biomarkers for salt‐sensitive hypertension

Journal of cellular and molecular medicine, 2020-07, Vol.24 (13), p.7254-7265 [Peer Reviewed Journal]

2020 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd ;2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.15285 ;PMID: 32410228

Full text available

17
Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents
Material Type:
Article
Add to My Research

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents

Journal of cellular and molecular medicine, 2021-11, Vol.25 (21), p.10073-10087 [Peer Reviewed Journal]

2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16940 ;PMID: 34647412

Full text available

18
NAADP‐induced intracellular calcium ion is mediated by the TPCs (two‐pore channels) in hypoxia‐induced pulmonary arterial hypertension
Material Type:
Article
Add to My Research

NAADP‐induced intracellular calcium ion is mediated by the TPCs (two‐pore channels) in hypoxia‐induced pulmonary arterial hypertension

Journal of cellular and molecular medicine, 2021-08, Vol.25 (15), p.7485-7499 [Peer Reviewed Journal]

2021 The Authors. published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. ;2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.16783 ;PMID: 34263977

Full text available

19
Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction
Material Type:
Article
Add to My Research

Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction

Journal of cellular and molecular medicine, 2019-10, Vol.23 (10), p.6666-6678 [Peer Reviewed Journal]

2019 The Authors. published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14542 ;PMID: 31368189

Full text available

20
MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP
Material Type:
Article
Add to My Research

MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP

Journal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5165-5175 [Peer Reviewed Journal]

2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.14385 ;PMID: 31240850

Full text available

Results 1 - 20 of 249  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2006  (13)
  2. 2006 To 2009  (19)
  3. 2010 To 2013  (37)
  4. 2014 To 2018  (49)
  5. After 2018  (131)
  6. More options open sub menu

Searching Remote Databases, Please Wait